Discordant varicella-zoster virus glycoprotein C expression and localization between cultured cells and human skin vesicles

Virology

Volumn 382, Issue 2, 2008, Pages 171-181

  Storlie, Johnathan ^a   Carpenter, John E ^a   Jackson, Wallen ^a   Grose, Charles ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Glycoprotein C; Marek's disease virus; Varicella zoster virus; VZV skin vesicles; VZV transcription

Indexed keywords

HEXAMETHYLENEBISACETAMIDE; MESSENGER RNA; PROTEIN C;

ARTICLE; CELL CULTURE; CHICKENPOX; CONTROLLED STUDY; HERPES ZOSTER; HUMAN; HUMAN CELL; IMAGING; INFECTION; INOCULATION; KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SKIN; VARICELLA ZOSTER VIRUS;

ACETAMIDES; CELLS, CULTURED; CHICKENPOX; GENE EXPRESSION; GENES, VIRAL; GIANT CELLS; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; KINETICS; RNA, MESSENGER; RNA, VIRAL; SKIN; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS; VIRUS REPLICATION;

GALLID HERPESVIRUS 2; HUMAN HERPESVIRUS 3;

EID: 56349113766     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.09.031     Document Type: Article

References (36)

1. Baigent S.J., Smith L.P., Currie R.J., and Nair V.K. Correlation of Marek's disease herpesvirus vaccine virus genome load in feather tips with protection, using an experimental challenge model. Avian Pathol. 36 6 (2007) 467-474
2. Carpenter J.E., Hutchinson J.A., Jackson W., and Grose C. Egress of light particles among filopodia on the surface of varicella-zoster virus-infected cells. J. Virol. 82 6 (2008) 2821-2835
3. Cohen J.I., and Seidel K.E. Absence of varicella-zoster virus (VZV) glycoprotein V does not alter growth of VZV in vitro or sensitivity to heparin. J. Gen. Virol. 75 Pt 11 (1994) 3087-3093
4. Cohrs R.J., Gilden D.H., Gomi Y., Yamanishi K., and Cohen J.I. Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of varicella-zoster virus. J. Virol. 80 5 (2006) 2076-2082
5. de Boer G.F., Pol J.M., and Oei H.L. Biological characteristics of Marek's disease vaccine CVI-988 clone C1. Vet. Q. 9 Suppl. 1 (1987) 16S-28S
6. Denesvre C., Blondeau C., Lemesle M., Le Vern Y., Vautherot D., Roingeard P., and Vautherot J.F. Morphogenesis of a highly replicative EGFPVP22 recombinant Marek's disease virus in cell culture. J. Virol. 81 22 (2007) 12348-12359
7. Gershon A., Cosio L., and Brunell P.A. Observations on the growth of varicella-zoster virus in human diploid cells. J. Gen. Virol. 18 (1973) 21-31
8. Grose C. The synthesis of glycoproteins in human melanoma cells infected with varicella-zoster virus. Virology 101 1 (1980) 1-9
9. Grose C. Glycoproteins encoded by varicella-zoster virus: biosynthesis, phosphorylation, and intracellular trafficking. Annu. Rev. Microbiol. 44 (1990) 59-80
10. Grose C. Varicella zoster virus infections: chickenpox, shingles and varicella vaccine. In: Glaser R., and Jones J.F. (Eds). "Herpesvirus Infections" (1994), Marcel Dekker, New York 117-185
11. Grose C., and Brunell P.A. Varicella-zoster virus: isolation and propagation in human melanoma cells at 36 and 32 degrees C. Infect. Immun. 19 1 (1978) 199-203
12. Grose C., and Ng T.I. Intracellular synthesis of varicella-zoster virus. J. Infect. Dis. 166 Suppl. 1 (1992) S7-S12
13. Grose C., Perrotta D.M., Brunell P.A., and Smith G.C. Cell-free varicella-zoster virus in cultured human melanoma cells. J. Gen. Virol. 43 1 (1979) 15-27
14. Grose C., Edwards D.P., Friedrichs W.E., Weigle K.A., and McGuire W.L. Monoclonal antibodies against three major glycoproteins of varicella-zoster virus. Infect. Immun. 40 1 (1983) 381-388
15. Grose C., Maresova L., Medigeshi G., Scott G., and Thomas G. Endocytosis of varicella-zoster virus glycoproteins: virion envelopment and egress. In: Sandri-Goldin R. (Ed). "Advances in Alpha Herpesviruses" (2006), Caister Press, Norfolk UK
16. Heineman T.C., and Hall S.L. Role of the varicella-zoster virus gB cytoplasmic domain in gB transport and viral egress. J. Virol. 76 2 (2002) 591-599
17. Honess R.W., and Roizman B. Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J. Virol. 14 1 (1974) 8-19
18. Jarosinski K.W., Margulis N.G., Kamil J.P., Spatz S.J., Nair V.K., and Osterrieder N. Horizontal transmission of Marek's disease virus requires US2, the UL13 protein kinase, and gC. J. Virol. 81 19 (2007) 10575-10587
19. Kennedy P.G.E., Grinfeld E., Craigon M., Vierlinger K., Roy D., Forster T., and Ghazal P. Transcriptomal analysis of varicella-zoster virus infection using long oligonucleotide-based microarrays. J. Gen. Virol. 86 10 (2005) 2673-2684
20. Kinchington P.R., Ling P., Pensiero M., Gershon A., Hay J., and Ruyechan W.T. A possible role for glycoprotein gpV in the pathogenesis of varicella-zoster virus. Adv. Exp. Med. Biol. 278 (1990) 83-91
21. Kinchington P.R., Ling P., Pensiero M., Moss B., Ruyechan W.T., and Hay J. The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka). J. Virol. 64 9 (1990) 4540-4548
22. Levine M., Krikos A., Glorioso J.C., and Homa F.L. Regulation of expression of the glycoprotein genes of herpes simplex virus type 1 (HSV-1). Adv. Exp. Med. Biol. 278 (1990) 151-164
23. Montalvo E.A., and Grose C. Assembly and processing of the disulfide-linked varicella-zoster virus glycoprotein gpII(gB). J. Virol. 61 9 (1987) 2877-2884
24. Osterrieder N., Kamil J.P., Schumacher D., Tischer B.K., and Trapp S. Marek's disease virus: from miasma to model. Nat. Rev. Microbiol. 4 4 (2006) 283-294
25. Parcells M.S., Lin S.F., Dienglewicz R.L., Majerciak V., Robinson D.R., Chen H.C., Wu Z., Dubyak G.R., Brunovskis P., Hunt H.D., Lee L.F., and Kung H.J. Marek's disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV. J. Virol. 75 11 (2001) 5159-5173
26. Peters G., Tyler S., Grose C., Severini A., Gray M., Upton C., and Tipples G. A full genome phylogenetic analysis of varicella-zoster virus reveals a novel origin of replication-based genotyping scheme and evidence of recombination between major circulating clades. J. Virol. 80 19 (2006) 9850-9860
27. Preston C.M., and McFarlane M. Cytodifferentiating agents affect the replication of herpes simplex virus type 1 in the absence of functional VP16. Virology 249 2 (1998) 418-426
28. Stingley S.W., Ramirez J.J.G., Aguilar S.A., Simmen K., Sandri-Goldin R.M., Ghazal P., and Wagner E.K. Global analysis of herpes simplex virus type 1 transcription using an oligonucleotide-based DNA Microarray. J. Virol. 74 21 (2000) 9916-9927
29. Storlie J., Jackson W., Hutchinson J., and Grose C. Delayed biosynthesis of varicella-zoster virus glycoprotein C: upregulation by hexamethylene bisacetamide and retinoic acid treatment of infected cells. J. Virol. 80 19 (2006) 9544-9556
30. Swain M.A., Peet R.W., and Galloway D.A. Characterization of the gene encoding herpes simplex virus type 2 glycoprotein C and comparison with the type 1 counterpart. J. Virol. 53 2 (1985) 561-569
31. Tischer B.K., Schumacher D., Chabanne-Vautherot D., Zelnik V., Vautherot J.F., and Osterrieder N. High-level expression of Marek's disease virus glycoprotein C is detrimental to virus growth in vitro. J. Virol. 79 10 (2005) 5889-5899
32. Tournier P., Cathala F., and Bernhard W. [Ultrastructure and intracellular development of varicella virus: observations by electron microscopy.]. Presse Med. 65 52 (1957) 1229-1234
33. Weigle K.A., and Grose C. Common expression of varicella-zoster viral glycoprotein antigens in vitro and in chickenpox and zoster vesicles. J. Infect. Dis. 148 4 (1983) 630-638
34. Yang W.C., Devi-Rao G.V., Ghazal P., Wagner E.K., and Triezenberg S.J. General and specific alterations in programming of global viral gene expression during infection by VP16 activation-deficient mutants of herpes simplex virus type 1. J. Virol. 76 24 (2002) 12758-12774
35. Zhang Y.F., Devi-Rao G.B., Rice M., Sandri-Goldin R.M., and Wagner E.K. The effect of elevated levels of herpes simplex virus alpha-gene products on the expression of model early and late genes in vivo. Virology 157 1 (1987) 99-106
36. Zhu Z., Gershon M.D., Ambron R., Gabel C., and Gershon A.A. Infection of cells by varicella zoster virus: inhibition of viral entry by mannose 6-phosphate and heparin. Proc. Natl. Acad. Sci. U. S. A. 92 8 (1995) 3546-3550